| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |